Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism

Biancur, Douglas E., Paulo, Joao A., Małachowska, Beata, Quiles Del Rey, Maria, Sousa, Cristovão M., Wang, Xiaoxu, Sohn, Albert S. W., Chu, Gerald C. +5 more·2017·Nature Communications
DOI 10.1038/ncomms15965

Cited by (315)

Items 201–300 of 315

  1. Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC
    Philip Dujardin, Anna K. Baginska, Sebastian Urban, Barbara M. Grüner · 2021 · Cancers
  2. Inhibition of GLS1 and ASCT2 Synergistically Enhances the Anticancer Effects in Pancreatic Cancer Cells
    Dong-Hwan Kim, Dong Joon Kim, Seongjun Park, Won‐Jun Jang, Chul‐Ho Jeong · 2025 · Journal of Microbiology and Biotechnology
  3. Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents
    Chiara Vagaggini, Pasqualina D’Ursi, Federica Poggialini, Paola Fossa, Valeria Francesconi, Gabriele Trombetti, Alessandro Orro, Elena Dreassi, Silvia Schenone, Michele Tonelli et al. · 2025 · Bioorganic Chemistry
  4. Unraveling and targeting RAS-driven metabolic signaling for therapeutic gain
    Jonathan M. DeLiberty, Ryan N. Robb, Claire E. Gates, Kirsten L. Bryant · 2022 · Advances in cancer research
  5. Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma
    Liangsong Zhu, Yilun Hong, Zi-Ran Zhu, Jiwei Huang, Jianfeng Wang, Ge Li, Xiaoyu Wu, Yonghui Chen, Yunze Xu, Liang Zheng et al. · 2024 · Cell Death and Disease
  6. Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction
    Tianhong Teng, Han Shi, Yan‐Ying Fan, Pengfei Guo, Jin Zhang, Xinyu Qiu, Jianghua Feng, Heguang Huang · 2024 · Scientific Reports
  7. Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives
    Ari Hashimoto, Shigeru Hashimoto · 2024 · Cancers
  8. Mesoporous High‐Entropy Oxides Nanoplatform Decodes Paired‐Plasma Metabolic Fingerprinting of Pancreatic Cancer
    Yue Sun, Wenhe Xie, Fangying Shi, Jichun Li, Hongxiu Yu, Yongjian Jiang, Chunhui Deng, Yonghui Deng · 2025 · Advanced Materials
  9. Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
    Ashley J. Hoskin, Amy K. Holt, Danny Legge, T J Collard, Ann Caroline Williams, Emma E. Vincent · 2023 · Exploration of Targeted Anti-tumor Therapy
  10. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
    Vipin Rawat, Patrick Ryan DeLear, Prarthana Prashanth, Mete Emir Özgürses, Anteneh T. Tebeje, Philippa A. Burns, Kelly O. Conger, Christopher Solı́s, Yasir Hasnain, Anna Novikova et al. · 2024 · JCI Insight
  11. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes
    Tingting Xu, Xiaoxuan Xu, Peng‐Cheng Liu, Hui Z. Mao, Shenghong Ju · 2020 · Frontiers in Oncology
  12. The Landscape of Cancer Metabolism as a Therapeutic Target
    Kenji Ohshima · 2025 · Pathology International
  13. Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
    Benjian Gao, Dongning Zheng, Zhihong Liu, Yu Guo, Yuntao Ye, Chen Zhou, Fengyi Yang, Jie Liu, Guangnian Zhang, Guoying Feng et al. · 2025 · Redox Biology
  14. Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment
    Jiarui Ma, Vipul Bhardwaj, Peter Edward Lobie, Vijay Pandey · 2026 · Molecular Cancer
  15. Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma
    Ari Hashimoto, Haruka Handa, Soichiro Hata, Shigeru Hashimoto · 2022 · Frontiers in Oncology
  16. Deciphering cellular plasticity in pancreatic cancer for effective treatments
    Md. Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El‐Rayes, Herbert Chen, Philip A. Philip, Asfar Sohail Azmi · 2024 · Cancer and Metastasis Reviews
  17. Cysteine metabolism at the crossroads of ferroptosis and cancer therapy
    Jaewang Lee, Jong‐Lyel Roh · 2025 · Critical Reviews in Oncology/Hematology
  18. SIRT6 promotes intrahepatic cholangiocarcinoma development by reprogramming glutamine metabolism via enhanced GLUL
    Mi Zhang, Chanyuan Chen, Haifeng Zhang, Tanqing Long, Tingjie Wang, Nanjin Ding, Ruitao Long, Hua Jian Wu, Zhilu Ma, Zhongyu Cheng et al. · 2025 · Gut
  19. Stable isotope-resolved metabolomics analyses of metabolic phenotypes reveal variable glutamine metabolism in different patient-derived models of non-small cell lung cancer from a single patient
    Connor Jarrett Kinslow, Michael Bousamra ll, Yihua Cai, Jun Yan, Pawel Konrad Lorkiewicz, Ahmad Al‐Attar, Jinlian Tan, Richard M. Higashi, Andrew N. Lane, Teresa W.‐M. Fan · 2024 · Metabolomics
  20. Effect of glutaminase inhibition on cancer-induced bone pain
    Jennifer Fazzari, Gurmit Singh · 2019 · Breast Cancer Targets and Therapy
  21. Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer
    Chen Liu, Shengming Deng, Zhiwen Xiao, Renquan Lu, Cheng He, Jingjing Feng, Xuxia Shen, Quanxing Ni, Weiding Wu, Xianjun Yu et al. · 2023 · Discover Oncology
  22. A hormetic response model for glutamine stress in cancer
    Shea F. Grenier, Cosimo Commisso · 2024 · Trends in cancer
  23. Revisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression
    He-Kang Ding, Qingwei Meng, Jun Mei Zhou, Li Chen, Jiaoti Huang, Bing Qiang Zhao, Lingfan Xu · 2025 · Chinese Medical Journal
  24. Emerging roles and regulatory mechanisms involved in glutamine metabolism
    Keun Woo Ryu, Tak Shun Fung, Craig B. Thompson · 2026 · Trends in Biochemical Sciences
  25. Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol
    Jun Gong, Arsen Osipov, Jeremy Lorber, Mourad Tighiouart, Albert K. Kwan, Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Abrahm Levi, Anser Ali Abbas et al. · 2023 · Biomedicines
  26. Photocatalytic C2-trifluoroethylation and perfluoroalkylation of 3-substituted indoles using fluoroalkyl halides
    Shivani Arora, Tavinder Singh, Anand Singh · 2024 · Organic & Biomolecular Chemistry
  27. Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma
    Miles Piper, Richard Blake Ross, Junxiao Hu, Shuichi Watanabe, Michael W. Knitz, Sanjana Mehrotra, Richard D. Shulick, Marco Del Chiaro, Sana D. Karam · 2023 · International Journal of Radiation Oncology*Biology*Physics
  28. Increased glucose availability sensitizes pancreatic cancer to chemotherapy
    Ali Vaziri Gohar, Jonathan J. Hue, Hallie J. Graor, Ata Abbas, Mehrdad Zarei, Omid Hajihassani, George Titomihelakis, John Feczko, Moeez Ghani Rathore, Rui Wang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Prognostic Significance of the Comprehensive Biomarker Analysis in Colorectal Cancer
    Vera I. Potievskaya, E. S. Tyukanova, Marina I Sekacheva, Zaki Z. A. Fashafsha, Anastasia S. Fatyanova, Mikhail Borisovich Potievskiy, Elena Kononova, Anna Kholstinina, Ekatherina Polishchuk, Peter Shegai et al. · 2025 · Life
  30. Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer
    Lingzhi Zhu, Kuishen Wu, Jianwei You, Wen Mi, Jie Xu, Liucheng Li, Fang Yang, Xinyi Xia, Haohang Yan, Fei Li et al. · 2025 · Molecular Cell
  31. Ulinastatin combined with glutamine improves liver function and inflammatory response in patients with severe acute pancreatitis.
    Li Zhao, Yanrong Ma, Qiuyue Li, Yuhan Wang · 2022 · PubMed Central
  32. Mechanism and application of nonessential amino acid deprivation associated with tumor therapy
    Shiqi Nong, Yuran Qian, Tingyue Zhang, Xueyan Zhou, Yuhao Wei, Xiaomeng Yin, Xuelei Ma · 2022 · MedComm – Future Medicine
  33. Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe
    Tingting Xu, Xiaoxuan Xu, Dongfang Liu, Di Chang, Siqi Li, Yeyao Sun, Jinbing Xie, Shenghong Ju · 2023 · Advanced Healthcare Materials
  34. Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite
    Minervo Perez, Daniel W. Bak, Sarah E. Bergholtz, Daniel R. Crooks, Bhargav S. Arimilli, Youfeng Yang, Eranthie Weerapana, William Marston Linehan, Jordan L. Meier · 2020 · Journal of Biological Chemistry
  35. Breaking the vicious cycle: Multifunctional nanomaterials targeting Tumor metabolic reprogramming to overcome T cell exhaustion and bone repair failure in bone tumors
    Shijin Guo, Ziyi Yan, Yuling Huang, Xueneng Hu, Huaiyuan Zhang, Yu Wang, Tinglin Zhang, Huifen Qiang, Minghao Xue, Jie Gao et al. · 2025 · Materials Today Bio
  36. Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
    Ruining Gong, Yonglu Hu, Qian Yu, Lin Fang, He Ren · 2023 · Journal of Pancreatology
  37. Serine-Driven Metabolic Plasticity Drives Adaptive Resilience in Pancreatic Cancer Cells
    Marcella Bonanomi, Sara Mallia, Mariafrancesca Scalise, Tecla Aramini, Federica Baldassari, Elisa Brivio, Federica Conte, Alessia Lo Dico, Matteo Bonas, Danilo Porro et al. · 2025 · Antioxidants
  38. Glutaminase inhibition ameliorates cancer-associated fibroblast lipid support of pancreatic cancer cell growth
    Xu Han, Laura C. Kim, Nicholas P. Lesner, Xuanyan Cai, Tran Ngoc Van Le, Marie Celeste Simon · 2025 · Cancer & Metabolism
  39. Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapy
    Dan Yan, Wenzhe Yi, Ting Wu, Shuangshuang Hu, Yan Ding, Xindi Qian, Zhiwen Zhao, Dangge Wang, Huae Xu, Ying Cai et al. · 2025 · Journal of Controlled Release
  40. New insights into microbiome metabolic mechanisms for pancreatic cancer therapy
    Yimao Wu, Kaiyu Zhang, Bo Xu, Nuonan Xu, Hongyu Zha, Mingjun Lin, Qidi He, Kexin Cheng, Gokhan Zengin, Mengyao Li · 2026 · TransMed
  41. Emerging pathways yielding opportunities for future treatments in pancreatic ductal adenocarcinoma
    Ashu Shah, Esther Johnson, Moorthy Palanimuthu Ponnusamy, Surinder K. Batra · 2025 · Expert Opinion on Therapeutic Targets
  42. Nutrition and Dietary Intervention in Cancer: Gaps, Challenges, and Future Perspectives
    Falak Zeb, Aqsa Mehreen, Huma Naqeeb, Muneeb Ullah, Afraa Waleed, Uzma Azeem Awan, Adnan Haider, Muhammad Naeem · 2024 · Cancer treatment and research
  43. Metabolic Plasticity of Tumor Cells: How They Do Adapt to Food Deprivation
    Céline A. Schoonjans, Bernard Gallez · 2020 · Advances in experimental medicine and biology
  44. Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets
    Robert Słotwiński, Gustaw Lech, Sylwia Małgorzata Słotwińska · 2021 · Central European Journal of Immunology
  45. Proceedings of the World Molecular Imaging Congress 2021, October 5-8, 2021: Late-Breaking Abstracts
    2021 · Molecular Imaging and Biology
  46. HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation
    Zhenting He, Yingying Gao, Ting Li, Chaowen Yu, Liping Ou, Chunli Luo · 2022 · International Journal of Oncology
  47. A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism
    Omid Hajihassani, Mehrdad Zarei, Asael Roichman, Alexander W. Loftus, Christina S. Boutros, Jonathan J. Hue, Parnian Naji, Jacob A. Boyer, Soubhi Tahhan, P. T. Gallagher et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Rewiring amino acids in cancer
    Yiqing Zhang, Jianxin Lyu, Hezhi Fang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  49. Machine learning-optimized metabolic biomarker panel for precision screening of early-stage pancreatic cancer in new-onset diabetes
    Weiliang Jiang, Zhiyuan Cheng, Rong Mu, Haoran Sun, Zihao Guo, Yu Guo, Dongyan Wang, Lijuan Yang · 2025 · Frontiers in Endocrinology
  50. A ketogenic diet sensitizes pancreatic cancer to glutamine metabolism inhibitors
    Omid Hajihassani, Asael Roichman, Jacob A. Boyer, Michal MacArthur, Ricardo A. Cordova, Alexander W. Loftus, Christina S. Boutros, Jonathan J. Hue, Parnian Naji, Soubhi Tahhan et al. · 2026 · Cell Reports Medicine
  51. Enhanced LDL uptake and PPARα signaling support OSCC cell survival under glutamine deprivation
    Luyao Cai, Yutong Chen, Shouyi Tang, Qing K. Wang, Yiming Xu, Yanxin Pan, Fan Yang, Tingyu Chen, Qianming Chen, Yu Zhou et al. · 2025 · Medical Oncology
  52. Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
    Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
  53. Deciphering cellular heterogeneity of pancreatic tumours
    Xiphias Ge Zhu, Kıvanç Birsoy · 2019 · Nature Cell Biology
  54. Role of glutamine metabolism in tuberculosis pathogenesis: a mini review
    Sadiya Parveen, William R. Bishai · 2024 · Frontiers in Tuberculosis
  55. TGF-β coordinates alanine synthesis and import for myofibroblast differentiation in pulmonary fibrosis
    Fei Li, Niv Vigder, David R. Ziehr, Mari Kamiya, Hung N. Nguyen, Diana E. Ferreyra Faustino, Aseel H. Khalil, Hilaire C. Lam, Matthew L. Steinhauser, Edy Yong Kim et al. · 2026 · JCI Insight
  56. Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies
    Zizhuo Li, Jiapeng Deng, Hai Wang, Tao Liu, Yaou Zhou, Pei Ouyang, Xuan Liang, Xian Zhang, Songtao Qi, Yaomin Li · 2025 · Genes & Diseases
  57. Natural Compounds as Potential Therapeutics for Pancreatic Cancer: A Narrative Review
    Xingda Lin, Tian Li, Rui-Xia Du, Guichen Li, Zhe Liu · 2025 · Current Drug Metabolism
  58. FOXO1 links KRAS G12D and G12V alleles to glutamine and nitrogen metabolism in colorectal cancer
    Suzan Ber, Ming Hui Yang, Marco Sciacovelli, Shamith Samarajiwa, Khushali Patel, Efterpi Nikitopoulou, Annie Howitt, Simon J. Cook, Ashok R. Venkitaraman, Christian Frezza et al. · 2025 · EMBO Reports
  59. NUFIP1 at the crossroads of ribophagy and disease: unveiling therapeutic implications
    Zhiyun Li, Yichen Bao, Xingpeng Yang, Yizhao Ma, Lin Qi, Xiaohui Du, Pengyue Zhao · 2025 · Journal of Translational Medicine
  60. GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic Cancer
    Rodrigo Curvello, Sandra Hauser, Michael Seifert, Christopher K. Barlow, Joel R. Steele, Emma Salisbury, Daniel Gerald Croagh, Kathryn S. Stok, Anna Verena Taubenberger, Ralf B. Schittenhelm et al. · 2026 · Advanced Science
  61. Metabolic regulation and immunosuppressive functions of lipid-associated macrophages in pancreatic ductal adenocarcinoma
    Tongyuan Zhang, Mingze Zhang, Xiaoqin He, Yuefeng Zhang · 2026 · Frontiers in Immunology
  62. Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
    Xinlong Zang, Ke Lei, Jia Wang, Ruining Gong, Chao Gao, Zhenghui Jing, Jinxiao Song, He Ren · 2024 · Chemical Engineering Journal
  63. Road Map to Defeat Pancreatic Cancer
    Lesley Paige Ferguson, David Arthur Tuveson · 2025 · Annual Review of Cancer Biology
  64. circEZH2 inhibits opening of mitochondrial permeability transition pore via interacting with PiC and up-regulating RSAD2
    Jianxiong Guo, Zhihao Liu, Di Zhang, Yunqiang Lai, Juan Gao, Xinyue Wang, Jiadi Lin, Xiangyin Zhang, Fenli Zhang, Xiaomin Zhao et al. · 2022 · Veterinary Microbiology
  65. Cancer insights from magnetic resonance spectroscopy of cells and excised tumors
    Marie‐France Penet, Raj Kumar Sharma, Santosh Kumar Bharti, Noriko Mori, Dmitri Artemov, Zaver M. Bhujwalla · 2022 · NMR in Biomedicine
  66. CETZOLE Analogs as Potent Ferroptosis Inducers and Their Target Identification Using Covalent/Affinity Probes
    Samkeliso Dlamini, Shahrzad Mohajeri, Nishanth Kuganesan, Shaimaa H. Sindi, Endri Karaj, Dewmi Sandaru Rathnayake, Jade McDaniel, William R. Taylor, L. M. Viranga Tillekeratne · 2024 · Journal of Medicinal Chemistry
  67. Metabolic Analysis of Tumor Cells Within Ameloblastoma at the Single‐Cell Level
    Rui‐Fang Li, Yi Fang Zhao, Qi‐Wen Man · 2024 · Oral Diseases
  68. Toxicological mechanisms of carbon polymers in accelerating cognitive decline in Alzheimer’s disease
    Zihe Qi, Juanjuan Cao, Jianghua Liu, Jian Chen, Shasha Chen, Luyao Zhang, Jingwen Xu, Di Wu, Yongning Wu, Guoliang Li · 2025 · Journal of Advanced Research
  69. A Multimodal Energy-Depletion Strategy for Cooperative Tumor Metabolism Regulation in Enhanced Cancer Therapy
    Jun Ma, Kun Chen, Xiaoyong Zhang, Yanni Lou, Yunmeng Bai, Yin‐Kwan Wong, Lei Zheng, Longying Li, Yan‐Wei Hu, Zhijie Li et al. · 2025 · Biomaterials Research
  70. Potential glutamine metabolism-related biomarkers were identified in osteoarthritis by bioinformatics
    Dongyun Li, Wang Chen, Yuelei Qing, Xitong Bao, Jingxiao Xu, Xinyu Wang, Wenping Bao, Xiaoying Wang · 2025 · Scientific Reports
  71. Interplay Between Glutamine Metabolism and Other Cellular Pathways: A Promising Hub in the Treatment of HNSCC
    Teresa Stefania Dell’Endice, Francesca Posa, Giuseppina Storlino, Lorenzo Sanesi, Lucio Lo Russo, Giorgio Mori · 2025 · Cells
  72. Mitochondrial Glutamine Metabolism Modulates Chemotherapy Sensitivity in Cancer Cells through Amphiregulin Signaling
    Filip Adam Novak, Jan Martin Hruby, Petra Eva Kolar · 2025 · Archive of International Journal of Cancer and Allied Science
  73. Targeting glutamine metabolism to modulate macrophage functions in the tumor microenvironment
    Shuyan Wu, Yuwei Peng, Qian Janice Wang, Zhaorong Li, Kewei Ge, Lihong Ye · 2026 · Discover Oncology
  74. FNA-based lipidomics reveals coordinated lipid metabolic remodeling in pancreatic cancer
    Shenhao Liu, Lifeng He, Gelin Jiang, 雷松岭, Bin Xu, Jian Xu, Songmei Lou · 2026 · Frontiers in Molecular Biosciences
  75. l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial
    Jun Gong, Hayato Muranaka, So Yung Choi, Mourad Tighiouart, Shrikant Bhute, Ezinne Aja, Jonathan P. Jacobs, Aleksandr B. Stotland, Jennifer E. Van Eyk, Omer Hany Miligy Elmadbouh et al. · 2026 · Nature Cancer
  76. NUFIP1+ stroma keeps PDAC fed
    Holly Sandborg, Mara H. Sherman · 2022 · Nature Cancer
  77. Molecular biomarkers in pancreatic ductal adenocarcinoma
    Junya Tsuboi, Reiko Yamada, YOSHIFUMI S. HIROKAWA · 2024 · Elsevier eBooks
  78. Glutamine metabolism in liver cancer: role in progression and potential therapeutic targeting
    Yashwant Kumar Ratre, Arundhati Mehta, Rajesh Sharma, Vivek Kumar Soni, Dhananjay Shukla, Vibhay Nath Tripathi, Naveen Kumar Vishvakarma · 2022 · Elsevier eBooks
  79. Distinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization
    Shun Kishimoto, Jeffrey Brender, Shingo Matsumoto, Tomohiro Seki, Nobu Oshima, Hellmut Merkle, Galen D. Reed, Albert P. Chen, Jan Henrik Ardenkjær‐Larsen, Jeeva Munasinghe et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Metabolic Plasticity of IDH1- Mutant Glioma Cell Lines Is Responsible for Low Sensitivity to Glutaminase Inhibition
    Victor Ruiz‐Rodado, Adrian Lita, Tyrone Dowdy, Orieta Celiku, Alejandra Cavazos Saldana, Herui Wang, Aiguo Li, Wei Zhang, Hua Song, Meili Zhang et al. · 2019 · SSRN Electronic Journal
  81. Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivity
    Hayato Muranaka, Sandrine Billet, Carlos Cruz‐Hernández, Johanna ten Hoeve, Gabrielle Gonzales, Omer Hany Miligy Elmadbouh, Le Zhang, Bethany Smith, Mourad Tighiouart, Sungyong You et al. · 2023 · Research Square
  82. Metabolism-oriented compound screen in physiological culture conditions identifies a NAMPT inhibitor highly effective against drug-naïve and -resistant melanoma cells
    Jasmin Renate Preis, Catherine Rolvering, Mélanie Kirchmeyer, Stephanie Kreis, Iris Behrmann, Claude Haan · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Targeting glutamine metabolism enhances tumor specific immunity by inhibiting the generation of MDSCs and reprogramming tumor associated macrophages
    Min Hee Oh, Im‐Hong Sun, Liang Zhao, Robert D. Leone, Im-Meng Sun, Wei Xu, Samuel L. Collins, Ada J Tam, Richard L. Blosser, Chirag H. Patel et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Role of Mitochondria in Pancreatic Metabolism, Diabetes, and Cancer
    Noble Kumar Talari, Ushodaya Mattam, Naresh Babu V. Sepuri · 2019 · Springer eBooks
  85. Nutriments et cancer : alliés ou ennemis ?
    Fabienne Guillaumond, Sophie Vasseur · 2020 · Cahiers de Nutrition et de Diététique
  86. Liver-Type Glutaminase is an Essential and Druggable Metabolic Node in Defined Breast Cancer Subtypes
    Michael J. Lukey, Ahmad A. Cluntun, William P. Katt, Miao-Chong Joy Lin, Joseph E. Druso, Sekar Ramachandran, Jon W. Erickson, Zhihan-Emily Wang, Bryant S. Blank, Richard A. Cerione · 2018 · SSRN Electronic Journal
  87. Glutamine is required for M1-like polarization in response to Mycobacterium tuberculosis infection
    Qingkui Jiang, Yunping Qiu, Irwin J. Kurland, Karl Drlica, Selvakumar Subbian, Sanjay Tyagi, Lanbo Shi · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Targeting Metabolism
    Yoshiaki Sunami · 2020 · Molecular and translational medicine
  89. Faculty Opinions recommendation of Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model.
    Cynthia A. Reinhart‐King · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  90. Faculty Opinions recommendation of Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
    Malini Raghavan, Amanpreet Kaur · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  91. Faculty Opinions recommendation of Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.
    Thierry Galli · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  92. Development and validation of lncRNAs–based Nomogram for prognosis prediction of hepatocellular carcinoma
    Tang Hong, Han Zhao, Fei-fei Zhao, Min Xie, ying zhu · 2022 · Research Square
  93. Pancreatic cancer cells crave glutamine for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway
    Chen Liu, Shengming Deng, Zhiwen Xiao, Renquan Lu, Cheng He, Jingjing Feng, Xuxia Shen, Quanxing Ni, Weiding Wu, Xianjun Yu et al. · 2022 · Research Square
  94. KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1
    Suzan Ber, Ming Hui Yang, Marco Sciacovelli, Shamith Samarajiwa, Khushali Patel, Efterpi Nikitopoulou, Annie Howitt, Simon J. Cook, Ashok R. Venkitaraman, Christian Frezza et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects
    Zihao Ye, Hao Wu, Zhanhao Li, Ruyu Ye, Yingliang Rao, Bin Liu, Baoshan Gao · 2025 · Frontiers in Oncology
  96. Macropinocytosis enables metabolic recycling of extracellular DNA in cancer cells
    Wen‐Hsuan Yang, Olivia T. Stamatatos, Evdokia Michalopoulou, Ava Sann, Paolo Cifani, Linda Van Aelst, Justin R. Cross, Tse-Luen Wee, Michael J. Lukey · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Metabolic signatures in gastroenteropancreatic neuroendocrine neoplasms: unraveling diagnostic and prognostic insights
    Reydson Alcides de Lima-Souza, Tayná Figueiredo Maciel, Moisés Willian Aparecido Gonçalves, Fernanda Cristina Poscai Ribeiro, Rodrigo A. Maioral, João Figueira Scarini, Heloisa P Soraes, Gary Chris Fillmore, Erika Said Abu Egal · 2025 · Frontiers in Endocrinology
  98. Protein S -acylation dynamics provide metabolic plasticity to acute myeloid leukemia cells
    Nithya Balasundaram, Ayşegül Erdem, Azeem Sharda, Veerle W. Daniëls, Phillip L. Chea, Fleur Leguay, YOUZHONG LIU, Mark A. Keibler, Charles Vidoudez, Andrew A. Lane et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus
    Ryohei Shoji, Hiroshi Tazawa, Shinji Kuroda, Takeyoshi Nishiyama, Yoshinori Kajiwara, Motohiko Yamada, Yasuo Nagai, Hiroaki Inoue, Naoyuki Hashimoto, Satoru Kikuchi et al. · 2026 · Molecular Therapy Oncology
  100. Etude de la reprogrammation des voies métaboliques des acides aminés au cours de la carcinogenèse pancréatique
    Victoire Gouirand · 2018